AAAAAA

   
Results: 1-12 |
Results: 12
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses
Authors: Notermans, DW De Jong, JJ Goudsmit, J Bakker, MR Roos, MTL Nijholt, L Cremers, J Hellings, JA Danner, SA De Ronde, A
Citation: Dw. Notermans et al., Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses, AIDS RES H, 17(11), 2001, pp. 1003-1008
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy
Authors: Kostense, S Raaphorst, FM Joling, J Notermans, DW Prins, JM Danner, SA Reiss, P Lange, JMA Teale, JM Miedema, F
Citation: S. Kostense et al., T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy, AIDS, 15(9), 2001, pp. 1097-1107
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations
Authors: Notermans, DW De Wolf, F Oudshoorn, P Cuijpers, HT Pirillo, M Tiller, FW McClernon, DR Prins, JM Lange, JMA Danner, SA Goudsmit, J Jurriaans, S
Citation: Dw. Notermans et al., Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations, AIDS RES H, 16(15), 2000, pp. 1507-1517
Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy
Authors: Hlavacek, WS Stilianakis, NI Notermans, DW Danner, SA Perelson, AS
Citation: Ws. Hlavacek et al., Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy, P NAS US, 97(20), 2000, pp. 10966-10971
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA
Authors: Rizzardi, GP De Boer, RJ Hoover, S Tambussi, G Chapuis, A Halkic, N Bart, PA Miller, V Staszewski, S Notermans, DW Perrin, L Fox, CH Lange, JMA Lazzarin, A Pantaleo, G
Citation: Gp. Rizzardi et al., Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA, J CLIN INV, 105(6), 2000, pp. 777-782
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy
Authors: Clark, DR Repping, S Pakker, NG Prins, JM Notermans, DW Wit, FWNM Reiss, P Danner, SA Coutinho, RA Lange, JMA Miedema, F
Citation: Dr. Clark et al., T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy, BLOOD, 96(1), 2000, pp. 242-249
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
Authors: Foudraine, NA Hovenkamp, E Notermans, DW Meenhorst, PL Klein, MR Lange, JMA Miedema, F Reiss, P
Citation: Na. Foudraine et al., Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients, AIDS, 13(2), 1999, pp. 177-184
Antigen-specific T-lymphocyte proliferative responses during highly activeantiretroviral therapy (HAART) of HIV-1 infection
Authors: Pontesilli, O Kerkhof-Garde, S Pakker, NG Notermans, DW Roos, MTL Klein, MR Danner, SA Miedema, F
Citation: O. Pontesilli et al., Antigen-specific T-lymphocyte proliferative responses during highly activeantiretroviral therapy (HAART) of HIV-1 infection, IMMUNOL LET, 66(1-3), 1999, pp. 213-217
Reversibility of the pathological changes in the follicular dendritic cellnetwork with treatment of HIV-1 infection
Authors: Zhang, ZQ Schuler, T Cavert, W Notermans, DW Gebhard, K Henry, K Havlir, DV Gunthard, HF Wong, JK Little, S Feinberg, MB Polis, MA Schrager, LK Schacker, TW Richman, DD Corey, L Danner, SA Haase, AT
Citation: Zq. Zhang et al., Reversibility of the pathological changes in the follicular dendritic cellnetwork with treatment of HIV-1 infection, P NAS US, 96(9), 1999, pp. 5169-5172
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults
Authors: Notermans, DW Pakker, NG Hamann, D Foudraine, NA Kauffmann, RH Meenhorst, PL Goudsmit, J Roos, MTL Schellekens, PTA Miedema, F Danner, SA
Citation: Dw. Notermans et al., Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults, J INFEC DIS, 180(4), 1999, pp. 1050-1056
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
Authors: Pontesilli, O Kerkhof-Garde, S Notermans, DW Foudraine, NA Roos, MTL Klein, MR Danner, SA Lange, JMA Miedema, F
Citation: O. Pontesilli et al., Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy, J INFEC DIS, 180(1), 1999, pp. 76-86
Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy
Authors: Kostense, S Raaphorst, FM Notermans, DW Joling, J Hooibrink, B Pakker, NG Danner, SA Teale, JM Miedema, F
Citation: S. Kostense et al., Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy, AIDS, 12(18), 1998, pp. F235-F240
Risultati: 1-12 |